The bidirectional tumor - Mesenchymal stromal cell interaction promotes the progression of head and neck cancer

Stem Cell Research and Therapy

Volumn 5, Issue 4, 2014, Pages

  Kansy, Benjamin A ^a   Dißmann, Philip A ^a   Hemeda, Hatim ^a,b   Bruderek, Kirsten ^a   Westerkamp, Anna M ^a   Jagalski, Vivien ^a   Schuler, Patrick ^a   Kansy, Katinka ^c   Lang, Stephan ^a   Dumitru, Claudia A ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1ALPHA; CONDITIONED MEDIUM; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CELL MOTION; CELL PROLIFERATION; CONDITIONED MEDIUM; DISEASE COURSE; FLOW CYTOMETRY; HEAD AND NECK TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE PROGRESSION; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MESENCHYMAL STROMAL CELLS; MICE, NUDE; TUMOR MICROENVIRONMENT;

EID: 84907080597     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt484     Document Type: Article

References (45)

1. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A, Cytotherapy 2005 7 393 395 10.1080/14653240500319234 16236628
2. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Hass R, Kasper C, Bohm S, Jacobs R, Cell Commun Signal 2011 9 12 10.1186/1478-811X-9-12 21569606
3. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X, Cell Biol Int 2006 30 681 687 10.1016/j.cellbi.2006.03.009 16870478
4. Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Nathan S, Das De S, Thambyah A, Fen C, Goh J, Lee EH, Tissue Eng 2003 9 733 744 10.1089/107632703768247412 13678450
5. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Prockop DJ, Gregory CA, Spees JL, Proc Natl Acad Sci U S A 2003 100 11917 11923 10.1073/pnas.1834138100 13679583
6. Isolation and characterization of adult stem cells from human salivary glands. Rotter N, Oder J, Schlenke P, Lindner U, Bohrnsen F, Kramer J, Rohwedel J, Huss R, Brandau S, Wollenberg B, Lang S, Stem Cells Dev 2008 17 509 518 10.1089/scd.2007.0180 18522496
7. Mesenchymal stem cells. Vaananen HK, Ann Med 2005 37 469 479 10.1080/07853890500371957 16278160
8. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Gao H, Priebe W, Glod J, Banerjee D, Stem Cells 2009 27 857 865 10.1002/stem.23 19350687
9. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M, Cancer Res 2010 70 10044 10050 10.1158/0008-5472.CAN-10-1254 21159629
10. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC, Stem Cells 2009 27 2614 2623 10.1002/stem.187 19650040
11. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D, Exp Cell Res 2010 316 3417 3424 10.1016/j.yexcr.2010.07.002 20633553
12. Mesenchymal stem cells in tumor development: emerging roles and concepts. Cuiffo BG, Karnoub AE, Cell Adh Migr 2012 6 220 230 10.4161/cam.20875 22863739
13. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC, Circulation 2005 111 150 156 10.1161/01.CIR.0000151812.86142.45 15642764
14. Human mesenchymal stem cells modulate B-cell functions. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A, Blood 2006 107 367 372 10.1182/blood-2005-07-2657 16141348
15. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, Shen B, Yin S, Liu W, Cui L, Li N, Cell Res 2008 18 846 857 10.1038/cr.2008.80 18607390
16. Interactions between human mesenchymal stem cells and natural killer cells. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M, Stem Cells 2006 24 74 85 10.1634/stemcells.2004-0359 16099998
17. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM, PLoS One 2010 5 10088 10.1371/journal.pone.0010088 20436665
18. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA, Nature 2007 449 557 563 10.1038/nature06188 17914389
19. Tissue-resident stem cells promote breast cancer growth and metastasis. Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU, Carcinogenesis 2009 30 589 597 10.1093/carcin/bgp036 19181699
20. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, Baik GH, Shibata W, Diprete B, Betz KS, Friedman R, Varro A, Tycko B, Wang TC, Cancer Cell 2011 19 257 272 10.1016/j.ccr.2011.01.020 21316604
21. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model. Tsukamoto S, Honoki K, Fujii H, Tohma Y, Kido A, Mori T, Tsujiuchi T, Tanaka Y, Int J Oncol 2012 40 163 169 21971610
22. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Yu JM, Jun ES, Bae YC, Jung JS, Stem Cells Dev 2008 17 463 473 10.1089/scd.2007.0181 18522494
23. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, Cao W, Han C, Chen Y, Exp Mol Pathol 2006 80 267 274 10.1016/j.yexmp.2005.07.004 16214129
24. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C, Blood 2003 102 3837 3844 10.1182/blood-2003-04-1193 12881305
25. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S, Saijo Y, Mol Med 2011 17 579 587 21424106
26. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, Touil I, Andre M, Grolleau JL, Peron JM, Chavoin JP, Bourin P, Pénicaud L, Casteilla L, Buscail L, Cordelier P, PLoS One 2009 4 6278 10.1371/journal.pone.0006278 19609435
27. Growth inhibitory effect of palatine tonsil-derived mesenchymal stem cells on head and neck squamous cell carcinoma cells. Lim YS, Lee JC, Lee YS, Lee BJ, Wang SG, Clin Exp Otorhinolaryngol 2012 5 86 93 10.3342/ceo.2012.5.2.86 22737289
28. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN, Cong C, Li SF, Long D, Tan WD, Mao YQ, Zhang J, Li YP, Cheng JQ, Cancer Biol Ther 2008 7 245 251 10.4161/cbt.7.2.5296 18059192
29. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M, Exp Mol Pathol 2003 75 248 255 10.1016/j.yexmp.2003.06.001 14611816
30. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S, Bhattacharya J, Blood 2009 113 4197 4205 10.1182/blood-2008-09-176198 19036701
31. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, Ye L, Zhang X, Cell Res 2008 18 500 507 10.1038/cr.2008.40 18364678
32. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD, Cancer Lett 2008 269 67 77 10.1016/j.canlet.2008.04.032 18571836
33. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian C, Li J, Yan X, Liu Y, Shao C, Zhao RC, Leukemia 2009 23 925 933 10.1038/leu.2008.384 19148141
34. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F 3rd, Stem Cells 2011 29 11 19 10.1002/stem.559 21280155
35. Minimal criteria for defining multipotent mesenchymal stromal cells, the International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606
36. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S, Stem Cells Dev 2010 19 693 706 10.1089/scd.2009.0365 20067407
37. Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Jakob M, Hemeda H, Janeschik S, Bootz F, Rotter N, Lang S, Brandau S, Stem Cells Dev 2010 19 635 644 10.1089/scd.2009.0245 19761404
38. The interleukin-8 pathway in cancer. Waugh DJ, Wilson C, Clin Cancer Res 2008 14 6735 6741 10.1158/1078-0432.CCR-07-4843 18980965
39. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W, Chayama K, Int J Cancer 2013 132 813 823 10.1002/ijc.27735 22821812
40. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. Annabi B, Naud E, Lee YT, Eliopoulos N, Galipeau J, J Cell Biochem 2004 91 1146 1158 10.1002/jcb.10763 15048870
41. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G, Arthritis Rheum 2013 65 1271 1281 10.1002/art.37908 23613363
42. Protein kinase C zeta regulates interleukin-8-mediated stromal-derived factor-1 expression and migration of human mesenchymal stromal cells. Picinich SC, Glod JW, Banerjee D, Exp Cell Res 2010 316 593 602 10.1016/j.yexcr.2009.11.011 19944094
43. Pleiotropic effects of cancer cells secreted factors on human stroma (mesenchymal) stem cells. Al-toub M, Almusa A, Almajed M, Al-Nbaheen M, Kassem M, Aldahmash A, Alajez NM, Stem Cell Res Ther 2013 4 114 10.1186/scrt325 24405819
44. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D, Stem Cells 2007 25 520 528 10.1634/stemcells.2006-0257 17053212
45. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D, Cancer Res 2008 68 4331 4339 10.1158/0008-5472.CAN-08-0943 18519693